Trial Profile
Comparison of Solifenacin Combined With Pelvic Floor Muscle and Whole Body Vibration Training With Solifenacin Alone in Patients With Overactive Bladder Syndrome. - A Prospective Randomized Parallel Group Trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms TOBS
- 19 May 2016 Status changed from recruiting to completed.
- 19 Dec 2011 Planned end date changed from 1 Jun 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 19 Dec 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.